Leone D. Patterson
Chief Financial Officer, Paratek Pharmaceuticals, Inc.
Companies
- Kalaris Therapeutics, Inc.Board member Apr 4, 2025 to now1
- ZymeworksEVP, Chief Bus & Fin Officer Sep 3, 2024 to now2
- Nkarta Therapeutics (United States)Board member Jul 9, 2020 to now3
- Tenaya Therapeutics, Inc.Chief Fin and Bus. Officer Jul 29, 2021 to Feb 27, 20244
- Climb Bio, Inc.Board member Aug 9, 2021 to Jun 1, 20225
- Avalanche BiotechnologiesPresident Oct 22, 2018 to Feb 18, 20216
- Avalanche BiotechnologiesChief financial officer Jun 16, 2016 to Feb 18, 20217
- Avalanche BiotechnologiesBoard member Feb 19, 2019 to May 8, 20208
- Avalanche BiotechnologiesChief executive officer Jun 18, 2018 to May 8, 20209
- Paratek Pharmaceuticals, Inc.Chief financial officer Jun 26, 2012 to Oct 30, 201410
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Tenaya Therapeutics, Inc. TNYA95,755 shares11$35.8K at $0.37Feb 23, 2024
As of each latest filing. The line shows shares held over time.
Recent filings
- Jan 6, 2026Granted 459 shares at $10.55 of CIK 193765312
- Feb 23, 2024Granted 35,000 shares of Tenaya Therapeutics, Inc.11
- Feb 16, 2024Sold 5,201 shares at $5.86 of Tenaya Therapeutics, Inc.13
- Aug 16, 2023Sold 4,452 shares at $3.81 of Tenaya Therapeutics, Inc.14
- Feb 15, 2023Granted 35,000 shares of Tenaya Therapeutics, Inc.15
- Feb 15, 2023Granted 30,000 shares of Tenaya Therapeutics, Inc.15
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5SEC EDGARClimb Bio, Inc., Board member
- 6SEC EDGARAvalanche Biotechnologies, President
- 7
- 8
- 9
- 10
- 11
- 12SEC EDGARForm 4 filed Jan 7, 2026
- 13SEC EDGARForm 4 filed Feb 16, 2024
- 14SEC EDGARForm 4 filed Aug 18, 2023
- 15SEC EDGARForm 4 filed Feb 17, 2023